 effect cyproheptadin locomot spastic patient spinal cord injuri effect cyproheptadin serotonerg antagonist patient spastic paresi spinal origin patient doubl blind crossov trial maxim mg/day patient spastic locomotor function patient open trial cyproheptadin minimum month optim dose patient treadmil full weight possibl bodi overhead har system cyproheptadin sustain ankl clonu episod spontan spasm patient manifest spastic patient bodi weight support bw locomot full weight cyproheptadin therapi normal time emg pattern patient cyproheptadin therapi tempor distanc chang improv joint angular displac contrast patient margin chang emg kinemat pattern speed preliminari result cyproheptadin spastic enhanc locomotor function spinal cord patient